Selective blockade of endothelin receptor subtypes on systemic and renal vascular responses to endothelin-1 and IRL1620, a selective endothelin ET(B)-receptor agonist, in anesthetized rats

Japanese Journal of Pharmacology

Volumn 71, Issue 3, 1996, Pages 213-222

  Matsuura, Takeshi ^a   Yukimura, Tokihito ^a   Kirn, Shokei ^a   Miura, Katsuyuki ^a   Iwao, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BQ 788; Endothelin 1; FR139317; Renal blood flow; Systemic blood pressure

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; RECEPTOR SUBTYPE; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PRESSOR RESPONSE; RAT; VASOCONSTRICTION;

EID: 0029789392     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.71.213     Document Type: Article

References (38)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415 (1988)
2. Firth JD, Ratcliffe PJ, Raine AE and Ledingham JG: Endothelin: an important factor in acute renal failure? Lancet 2, 1179-1182 (1988)
3. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T and Harris RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest 83, 336-342 (1989)
4. King AJ, Brenner BM and Anderson S: Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 256, F1051-F1058 (1989)
5. Miller WL, Redfield MM and Burnett J Jr: Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 83, 317-320 (1989)
6. Kon V and Badr KF: Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 40, 1-12 (1991)
7. Tomita K, Ujiie K, Nakanishi T, Tomura S, Matsuda O, Ando K, Shichiri M, Hirata Y and Marumo F: Plasma endothelin levels in patients with acute renal failure. N Engl J Med 321, 1127 (1989)
8. Firth JD and Ratcliffe PJ: Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest 90, 1023-1031 (1992)
9. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I and Hoover RL: Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 37, 1487-1491 (1990)
10. Fogo A, Hellings SE, Inagami T and Kon V: Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 42, 770-774 (1992)
11. Arai H, Hori S, Aramori I, Ohkubo H and Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348, 730-732 (1990)
12. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K and Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348, 732-735 (1990)
13. de-Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD and Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85, 9797-9800 (1988)
14. Warner TD, Mitchell JA, de-Nucci G and Vane JR: Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 13, S85-S88 (1989)
15. Yamashita Y, Yukimura T, Miura K, Okumura M and Yamamoto K: Effects of endothelin-3 on renal functions. J Pharmacol Exp Ther 259, 1256-1260 (1991)
16. B receptor agonist, IRL1620. Eur J Pharmacol 264, 399-405 (1994)
17. B receptor antagonist, BQ-788. Br J Pharmacol 113, 1257-1262 (1994)
18. Ihara M, Saeki T, Funabashi K, Nakamichi K, Yano M, Fukuroda T, Miyaji M, Nishikibe M and Ikemoto F: Two endothelin receptor subtypes in porcine arteries. J Cardiovasc Pharmacol 17, S119-S121 (1991)
19. 1,3,11,15]-endothelin-1 by BQ-123 in the anaesthetized rat. Br J Pharmacol 107, 912-918 (1992)
20. Cristol JP, Warner TD, Thiemermann C and Vane JR: Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br J Pharmacol 108, 776-779 (1993)
21. A receptor activation. Am J Physiol 264, R222-R226 (1993)
22. Fukuroda T, Nishikibe M, Ohta Y, Ihara M, Yano M, Ishikawa K, Fukami T and Ikemoto F: Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153. Life Sci 50, L107-L112 (1992)
23. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186, 867-873 (1992)
24. McMurdo L, Corder R, Thiemermann C and Vane JR: Incomplete inhibition of the presser effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol 108, 557-561 (1993)
25. Warner TD, Allcock GH, Corder R and Vane JR: Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 110, 777-782 (1993)
26. Wellings RP, Corder R, Doherty AM and Vane JR: Antagonism of renal and systemic responses to endothelin-1 infusion with PD 145065. Eur J Pharmacol 256, 201-204 (1994)
27. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M and Yano M: Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91, 4892-4896 (1994)
28. Lu G-W, Miura K, Yukimura T and Yamamoto K: Effects of extract from Clerodendron trichotomum blood pressure and renal function in rats and dogs. J Ethnophamacol 42, 77-82 (1994)
29. B receptor. Biochem Biophys Res Commun 184, 953-959 (1992)
30. A receptor antagonist. J Pharmacol Exp Ther 264, 1040-1046 (1993)
31. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K and Masaki T: The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86, 2863-2867 (1989)
32. B receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Br J Pharmacol 111, 515-520 (1994)
33. 11,13]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol 112, 477-486 (1994)
34. Williams D Jr, Jones KL, Pettibone DJ, Lis EV and Clineschmidt BV: Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175, 556-561 (1991)
35. Sudjarwo SA, Hori M, Takai M, Urade Y, Okada T and Karaki H: A novel subtype of endothelin B receptor mediating contraction in swine pulmonary vein. Life Sci 53, 431-437 (1993)
36. Nishiyama M, Moroi K, Shan LH, Yamamoto M, Takasaki C, Masaki T and Kimura S: Two different endothelin B receptor subtypes mediate contraction of the rabbit saphenous vein. Jpn J Pharmacol 68, 235-243 (1995)
37. Lidbury PS, Thiemermann C, Korbut R and Vane JR: Endothelins release tissue plasminogen activator and prostanoids. Eur J Pharmacol 186, 205-212 (1990)
38. Warner TD, Allcock GH, Mickley EJ, Corder R and Vane JR: Comparative Studies with the endothelin receptor antagonists BQ-123 and PD-142893 indicate at least 3 endothelin receptors. J Cardiovasc Pharmacol 22, S117-S120 (1993)